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ARTICLE
Mammalian γ2 AMPK regulates intrinsic heart rate
Arash Yavari et al.#
AMPK is a conserved serine/threonine kinase whose activity maintains cellular energy
homeostasis. Eukaryotic AMPK exists as αβγ complexes, whose regulatory γ subunit confers
energy sensor function by binding adenine nucleotides. Humans bearing activating mutations
in the γ2 subunit exhibit a phenotype including unexplained slowing of heart rate (brady-
cardia). Here, we show that γ2 AMPK activation downregulates fundamental sinoatrial cell
pacemaker mechanisms to lower heart rate, including sarcolemmal hyperpolarization-
activated current (If) and ryanodine receptor-derived diastolic local subsarcolemmal Ca2+
release. In contrast, loss of γ2 AMPK induces a reciprocal phenotype of increased heart rate,
and prevents the adaptive intrinsic bradycardia of endurance training. Our results reveal that
in mammals, for which heart rate is a key determinant of cardiac energy demand, AMPK
functions in an organ-speciﬁc manner to maintain cardiac energy homeostasis and deter-
mines cardiac physiological adaptation to exercise by modulating intrinsic sinoatrial cell
behavior.
DOI: 10.1038/s41467-017-01342-5 OPEN
Correspondence and requests for materials should be addressed to A.Y. (email: arash.yavari@well.ox.ac.uk)
or to H.A. (email: houman.ashraﬁan@cardiov.ox.ac.uk)
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Cellular survival and function depend fundamentally on theliberation of free energy, achieved through the inter-mediary process of ATP hydrolysis, to drive anabolic
processes. Cells have to contend with the challenge of ﬂuctuating
internal bioenergetic demands and environmental substrate
availability, necessitating a precise system of monitoring cellular
energetic status dynamically. In eukaryotic cells, the adenylate
charge-regulated sensor/effector arm of this system is recognized
to be AMP-activated protein kinase (AMPK), a serine/threonine
kinase existing as a heterotrimeric complex of catalytic α and
regulatory β and γ subunits1. The γ AMPK subunit—existing in
mammals as three isoforms (γ1, γ2, and γ3)—confers energy
sensing on the holoenzyme through competitive binding of
adenyl nucleotides at the interfaces of four tandem cystathionine
β-synthase (CBS) repeats2. AMPK is largely inactive under phy-
siological conditions due to Mg.ATP complexing2; however,
in response to energetic stress — corresponding to increased
AMP/ATP and/or ADP/ATP — AMPK activates catabolic
ATP–generating metabolic processes and represses anabolic
functions via direct phosphorylation and altered transcription3,
restoring cellular energy charge.
In contrast to unicellular eukaryotes, metazoans must
ensure energy homeostasis for the organism as a whole, coupling
energy (i.e., food) intake to metabolic requirements of diverse
multi-cellular tissues4. This transition necessitated the evolu-
tionary co-option of AMPK from a primordial cell-autonomous
fuel gauge to a systemic energy regulator responsive to multiple
hormonal and nutritional cues5, exempliﬁed by the contribution
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Fig. 1 Generation of the R299Q γ2 AMPK knock-in mouse and enrichment of γ2 AMPK in WT SA nodes. a Mean 24-h heart rate (HR) of human
heterozygous R302Q γ2 mutation carriers (age 41.2± 2.8 years) vs genotype-negative sibling controls (age 38.9± 2.3 years) (n= 10–15). All subjects had
any anti-arrhythmic drugs or β-adrenoceptor blockers discontinued for 5 days prior to ECG and none were on amiodarone. b Schematic of gene-targeting
strategy to generate the R299Q γ2 AMPK knock-in. Neo, neomycin selection cassette; FRT, Flp recombinase recognition target; red asterisk denotes
mutation in exon 7 of Prkag2. c γ2 AMPK-speciﬁc activity of freeze-clamped ex vivo perfused hearts measured by SAMS peptide phophorylation assay
in the absence or presence of AMP (n= 18–22). d Representative western blot of whole heart tissue from R299Q γ2 and WT mice for phospho-(p) ACC
(n= 11–15). e–g Cine MRI analysis of left ventricular (LV) mass (e), end-diastolic volume (EDV) (f) and ejection fraction (EF) (g) in R299Q γ2 and WT
mice aged 2 months (n= 8–19). h Cardiac tissue glycogen content from 12 month R299Q γ2 and WT mice together with a positive control heart from a
homozygous Gaa (encoding acid α-glucosidase) knockout mouse (n= 12–15). i, j Periodic acid-Schiff (PAS) staining (i) (scale bar, 5 µm) and quantiﬁcation
of glycogen content (j) (as %PAS-positive cells/ﬁeld) of SA node (SAN) sections (n= 12). k, l Quantitative real-time PCR (qRT-PCR) of γ2 and γ1 AMPK
isoform relative gene expression levels (normalized to β-actin) from normal murine SA node and LV (SAN, n= 4; LV, n= 10). m–o Western blot (m) and
densitometry (n, o) of γ2 and γ1 AMPK in normal murine SA node and LV, together with SA node positive (HCN4) and loading (GAPDH) controls
(n= 6–8). Uncropped western blots are shown in Supplementary Fig. 10. a, k, l, n, o Student’s t-test was performed. c Kruskal–Wallis test followed by
Dunn’s multiple comparisons test was performed. e–h, j One-way analysis of variance (ANOVA) followed by Holm–Sidak’s multiple comparisons test was
performed. *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. RE relative expression, AU arbitrary units. a, c, e–h, j–l, n, o Data are shown as means
± s.e.m.
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of hypothalamic AMPK to the central effect of hormones inﬂu-
encing feeding behavior, such as ghrelin6, leptin7, and thyroid
hormone8. In both mice and humans, activating mutations in γ2
AMPK that alter hypothalamic orexigenic neuronal excitability
and drive caloric surfeit9 suggest that AMPK activity, inﬂuenced
by the nucleotide sensing γ subunit, has adapted in these highly
specialized cells to function as a systemic energy sensor,
defending the metabolic requirements of the entire organism.
However, a role for regulation of organ-speciﬁc caloric
accounting by AMPK activity in cell populations beyond such
central neuronal circuits has not been reported.
The heart exhibits the highest organ-speciﬁc resting metabolic
rate of any organ10 and remarkable energetic stewardship, with
the highest work increment of any organ, achieving dynamic
workload of 5000–50,000 mmHg beats/min, typically at very
high heart rates (HRs), without any increase in free ADP levels.
HR scales linearly with myocardial oxygen consumption, with
the latter further increased by the enhanced contractility
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accompanying an increased HR11. As the background HR is set
by the intrinsic automaticity of the cardiac pacemaker—a popu-
lation of highly specialized sinoatrial (SA) cells—these observa-
tions suggest a direct link between SA cell ﬁring rate and cardiac
energy homeostasis.
In humans, activating mutations in the gene encoding the
γ2 subunit of AMPK (PRKAG2) result in an autosomal dominant
disorder whose heterogeneous phenotypic spectrum includes left
ventricular hypertrophy (LVH) and prominent electro-
physiological disturbances12,13. Cardiac-restricted transgenic
mouse models overexpressing human PRKAG2 mutations reca-
pitulate major aspects of this spectrum, including severe LVH,
ventricular pre-excitation, and propensity to sudden death14,15.
Histological analyses of hearts from these models and human
mutation carriers have identiﬁed cardiomyocyte glycogen accu-
mulation and suggested a direct role for glycogen in the patho-
genesis of pre-excitation14. However, the prominent sinus
bradycardia, which contributes to the substantial requirement for
early pacemaker implantation, remains poorly understood13,16,17.
Here, we use a combination of genetic, electrophysiological,
transcriptomic, and cellular approaches applied to genetic models
of altered AMPK function to examine its role in the regulation of
the mammalian cardiac pacemaker. Our results reveal an
important organ-speciﬁc function for γ2 AMPK in the regulation
of intrinsic SA cell ﬁring rate in health and disease, linking this
conserved cellular energy sensor to the control of mammalian SA
node and thereby myocardial energy homeostasis through its
inﬂuence on HR.
Results
γ2 AMPK activation induces sinus bradycardia. The majority
of cardiomyopathy-causing PRKAG2 mutations are missense
substitutions of highly conserved residues within or in close
proximity to the CBS motifs of the γ2 subunit of AMPK18. Stu-
dies of transgenic mice and acute viral transduction experi-
ments19 suggest that the primary effect of these γ2 mutations to
be basal activation of the enzyme complex, likely due to a failure
to adequately sense inhibitory ATP. Furthermore, the relative
proportions of the different γ subunits appear to be important; for
example, even overexpression of wild-type (WT) γ2 has been
associated with a cardiac phenotype in mice, including LVH and
glycogen excess14. This may reﬂect altered γ isoform stoichio-
metry (i.e., the γ1/γ2 ratio, with γ1 representing the physiologi-
cally predominant cardiac isoform)20.
We observed that humans carrying the R302Q mutation in
PRKAG2 (the most frequently described) exhibit sinus brady-
cardia with a signiﬁcantly lower resting HR compared with
genotype-negative sibling controls (Fig. 1a). To gain insights into
the pathogenesis of PRKAG2-related sinus bradycardia free of
confounders inherent to overexpression transgenesis, we used
gene-targeted mice with the R299Q mutation (orthologous to
R302Q in humans) introduced into murine Prkag2, permitting
the expression and regulation of mutant protein under endogen-
ous control mechanisms (Fig. 1b)9. Mice heterozygous (Het) for
the R299Q γ2 mutation were interbred to generate WT and
homozygous (Homo) mice. Competitive multiplex PCR con-
ﬁrmed expression of R299Q γ2 transcripts in mutant but not WT
mice (Supplementary Fig. 1a). Western blotting conﬁrmed
comparable cardiac γ2 and γ1 expression across genotypes
(Supplementary Fig. 1b–d). Cardiac γ2-speciﬁc basal AMPK
activity was increased in R299Q γ2 mice compared with WT
(Fig. 1c). Consistent with its proximity to the nucleotide-binding
site2 and previous reports18,21, activation of R299Q γ2 AMPK
complexes by AMP was limited compared with WT (Fig. 1c). In
R299Q γ2 hearts, a corresponding increase in the phosphoryla-
tion of acetyl-CoA carboxylase at Ser79, a canonical AMPK
target, was observed (Fig. 1d; Supplementary Fig. 1e), consistent
with a basal gain-of-function of γ2 AMPK complexes in vivo.
Cine MRI revealed no evidence for LVH or LV dilatation, but
R299Q γ2 mice exhibited a subtle reduction in contractile
performance at 2 months of age (Fig. 1e–g), with no progression
at 10 months (Supplementary Fig. 1f–i). Cardiac energetics, as
determined by in vivo 31P-MRS measurement of the phospho-
creatine/γ-ATP ratio, was unaltered at 2 months (Supplementary
Fig. 1j). Cardiac histology and ultrastructure of R299Q γ2 mice
appeared indistinguishable from WT mice (Supplementary
Fig. 2a, c). We found a small increase in biochemical cardiac
glycogen content in homozygous R299Q γ2 mice at 12 months
(Fig. 1h), associated with upregulation of several genes involved
in glucose transport (Slc2a1, Slc2a4) and glycogen metabolism
(Gyg, Pygm) (Supplementary Fig. 2b).
In contrast to ﬁndings in whole heart, detailed regional
histological analysis of SA node sections revealed a striking excess
of glycogen in R299Q γ2 mice (Fig. 1i, j; Supplementary
Fig. 2h–j), with increased maximal SA node thickness (Supple-
mentary Fig. 2e) but otherwise unremarkable histological
appearances (Supplementary Fig. 2d, f, g), including no evidence
of apoptosis on TUNEL staining, suggesting correspondingly
greater AMPK activation22 in the SA node. Accordingly, we
assessed γ isoform transcript expression in normal murine SA
nodes compared to left ventricles (LVs) and found Prkag2, but
not Prkag1, to be enriched in SA nodes (Fig. 1k, l). We observed
corresponding SA node enrichment of γ2 protein, but a striking
paucity of γ1, suggesting that γ2 is the predominant γ isoform in
this tissue (Fig. 1m–o; Supplementary Fig. 1k–m). We also
observed signiﬁcantly lower expression of α2 AMPK in the SA
node compared to the LV (Supplementary Fig. 1n, o).
Reminiscent of the sinus bradycardia of human R302Q
PRKAG2 mutation carriers (Fig. 1a), invasive electrophysiology
studies performed under isoﬂurane general anesthesia revealed a
reduction in sinus HR of homozygous R299Q γ2 mice in vivo
Fig. 2 γ2 AMPK activation lowers intrinsic HR by downregulating SA cell If and Ca2+ clock pacemaker mechanisms. a HR in beats per minute (bpm) of
R299Q γ2 and WT mice under anesthesia (n= 7–12). b HR during ex vivo-isolated cardiac perfusion (n= 6–11). c Representative action potentials from SA
cells isolated from R299Q γ2 and WT mice. dMean beating rate of SA cells from groups illustrated in c (n= 17 cells). e qRT-PCR validation of differentially
expressed genes on SA node microarray (n= 3). FC fold-change. f, g Representative western blot (f) and analysis (g) of HCN4 levels in SA nodes from
R299Q γ2 and WT mice. h Representative SA cell If traces during steps to −125 mV. iMean fully activated I/V curves (If density plotted against membrane
voltage) recorded in WT and R299Q γ2 SA cells. Linear data ﬁtting yielded signiﬁcant differences (P< 0.0001) in If slope conductance (648 and 333 pS/pF
for WT and homozygous R299Q γ2 SA cells, respectively) (n= 8–10 cells/2–6 mice). jMean voltage dependence of If activation of WT and R299Q γ2 SA
cells (n= 6 per genotype). Half-activation voltages (V1/2, mV) and inverse-slope factors (s, mV) depicted. k Representative confocal line-scan images and
Ca2+ transients of isolated, single, permeabilized WT, and homozygous R299Q γ2 SA node cells bathed in 50 nmol/L free [Ca2+]. l–n Mean spontaneous
local Ca2+ release (LCR) amplitude (l) expressed as peak value (F) normalized to minimal (F0) ﬂuorescence, size (m), and duration (n). o, p Ca2+ signal of
individual LCR (o) and LCR ensembl (p) (n= 15–17 cells/3 mice per genotype). Uncropped western blots are shown in Supplementary Fig. 10. a, b, d
One-way ANOVA followed by Holm–Sidak’s multiple comparisons test was performed. i Comparison of the slopes of linear regression lines was
performed. e, g, l–p Student’s t-test was performed. *P< 0.05, **P< 0.01, ***P< 0.001, ****P< 0.0001. a, b, d, e, g, l–p Data are shown as means± s.e.m.
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(Fig. 2a). The PR interval and anterograde atrioventricular
conduction parameters were not signiﬁcantly different to WT,
with no evidence of ventricular pre-excitation either at baseline or
with programmed atrial stimulation (Supplementary Table 1).
Ambulatory HR recordings conﬁrmed invasive ﬁndings, with
marked sinus bradycardia in homozygous R299Q γ2 compared
with WT mice (416± 13 bpm vs 549± 15 bpm, respectively,
P< 0.0001, Student’s t-test; Supplementary Fig. 3a, b).
γ2 AMPK activation reduces SA cell automaticity. Assessment
of isolated perfused hearts from R299Q γ2 mice demonstrated a
lower intrinsic HR (Fig. 2b). As a corollary, isolated SA cells from
R299Q γ2 mice exhibited reduced basal ﬁring rate but unaltered
maximum diastolic potential (MDP) (Fig. 2c, d; Supplementary
Fig. 3c). We next measured SA cell rate responses to catechola-
mine and muscarinic stimulation. We observed signiﬁcant
increases in SA cell ﬁring rates in response to the β-adrenergic
receptor agonist isoproterenol in homozygous R299Q γ2 mice,
with a magnitude of change from baseline comparable to WT
mice, thereby reaching a marginally lower maximal rate (Sup-
plementary Fig. 3e). Both genotypes exhibited profound reduc-
tions in SA cell ﬁring rates in response to the endogenous
muscarinic receptor agonist acetylcholine (ACh) (Supplementary
Fig. 3f). These data indicate that the activating R299Q γ2 AMPK
mutation, in the context of a broadly healthy SA node with
chronotropic competence, induces intrinsic sinus bradycardia in
mice by reducing the basal SA cell ﬁring rate while retaining high
responsivity to catecholamine and cholinergic rate modulation.
γ2 AMPK activation reprograms the SA node transcriptome.
To delineate the molecular mechanisms contributing to the
intrinsic sinus bradycardia of R299Q γ2 mice, we obtained SA
node gene expression proﬁles and identiﬁed signiﬁcant differ-
ences in gene expression (Supplementary Fig. 4; Supplementary
Tables 2 and 3). These included: changes suggestive of a transi-
tion of the SA node to a less nodal phenotype (upregulation in
Myl2, Myl3, Nppb, and Tnnt3); downregulation of transcriptional
regulators critical to SA node development and function (Isl1 and
Tbx3)23,24; alterations in constituents of the sarcolemmal mem-
brane voltage clock (upregulation in Kcna5 and Kcnv2); genes
involved in Ca2+ homeostasis or regulation of the sarcoplasmic
reticulum (SR) Ca2+ clock (upregulation in Parv, Pln, and
downregulation in Atp2a1, Calr, Casq1, and Ppp1r1b); and genes
related to AMPK’s canonical function (i.e., altered expression of
genes involved in glucose homeostasis and glycogen metabolism
with upregulation in Fbp2, Ganc, Pfkfb2, Phkb, Pgm3, and
downregulation in Pygm and Hk1). These genes were observed to
cluster around and interact with (Supplementary Figs. 5–7) a
network of key regulators of pacemaker clock function, including
genes encoding cAMP-activated protein kinase (Pka) (Supple-
mentary Fig. 5, network 2; Supplementary Fig. 6, network 5),
short stature homeobox 2 (Shox2) (Supplementary Fig. 6, net-
work 2), the cardiac ryanodine receptor (Ryr2), and the calcium
and calmodulin-dependent protein kinase II (CamkII) (Supple-
mentary Fig. 6, network 6). Quantitative real-time PCR (qRT-
PCR) of SA nodes conﬁrmed many of these changes (Fig. 2e),
suggesting that γ2 AMPK activation has a transcriptional inﬂu-
ence to remodel the coupled-clock and accounting for the
observed changes in SA node function.
γ2 AMPK activation downregulates SA If and spontaneous
LCRs. The transcription factors ISL1 and TBX3 critically promote
the SA cell-speciﬁc gene program23,24, including expression of
Hcn4. HCN4, highly expressed in the mammalian SA node, is one
of four hyperpolarization-activated cyclic nucleotide-gated
channel isoforms constituting f-channels which are responsible
for the sarcolemmal hyperpolarization-activated “funny” current,
If, critically contributing to the spontaneous depolarization of
pacemaker cells, and whose reduced expression is associated with
sinus bradycardia25. We measured SA node HCN4 protein
expression and found a marked reduction in homozygous R299Q
γ2 mice (Fig. 2f, g; Supplementary Fig. 3d). Patch-clamping of
isolated homozygous R299Q γ2 SA cells revealed a reduction in If
density with a substantial and signiﬁcant reduction in whole-cell
If conductance compared with WT (Fig. 2h, i), but no alteration
in the If voltage-dependence of activation (Fig. 2j), supporting the
contribution of lower f-channel density to reduced SA node If. SA
cells from both genotypes exhibited similar shifts in the If acti-
vation curve upon β-adrenoceptor or muscarinic stimulation
using isoproterenol (Iso) or acetylcholine (ACh), respectively,
suggesting unperturbed If modulation by these agonists
(Supplementary Fig. 3g, h).
Spontaneous rhythmic SR local Ca2+ release (LCR) also
crucially inﬂuences SA cell automaticity26. Given the gene
expression proﬁle ﬁndings, we undertook confocal imaging of
LCRs in individual permeabilized WT and R299Q γ2 SA cells (in
which the impact of HCN4 and other sarcolemmal electrogenic
molecules constituting the membrane clock are uncoupled from
the Ca2+ clock) bathed in ﬁxed physiologic free [Ca2+]. We found
signiﬁcantly lower mean LCR amplitude, size, and duration in
R299Q γ2 vs WT SA cells (Fig. 2k–n), resulting in a >50% lower
spontaneous Ca2+ signal of individual and ensemble LCRs
(Fig. 2o, p), which activate the Na+/Ca2+ exchanger current
(Incx) in intact SA cells during diastolic depolarization. Consistent
with the transcriptome data, immunohistochemistry of isolated
SA cells from homozygous R299Q γ2 mice revealed signals for
greater phospholamban (PLN) protein expression (Supplemen-
tary Fig. 3i), a key negative modulator of LCR periodicity via its
inhibitory effects on the SR Ca2+ uptake pump, sarco(endo)
plasmic reticulum Ca2+-ATPase (SERCA)26. We veriﬁed this
ﬁnding quantitatively using western blotting, conﬁrming
increased phospholamban content in homozygous R299Q γ2
SA nodes compared with WT SA nodes, both in absolute terms
and when expressed relative to its cognate protein, SERCA
(Supplementary Fig. 3j, l), consistent with reduced SR Ca2+
replenishment. However, we identiﬁed no signiﬁcant effect of the
R299Q γ2 mutation on levels of other key constituents of
spontaneous intracellular Ca2+ cycling contributing to pacemaker
function, including SERCA itself, calsequestrin (CASQ1), the
cardiac ryanodine receptor (RYR2), the Na+/Ca2+exchanger
(NCX1), or L-type Ca2+ channels (LTCC) (Supplementary Fig. 3k,
m–p). Altogether, these data indicate that γ2 AMPK activation
co-ordinately reduces two fundamental components of the SA cell
intrinsic pacemaker mechanism: If and LCRs.
WGCN analysis links Prkag2 to a network of pacemaker genes.
To conﬁrm AMPK’s ability to acutely and reversibly
alter intrinsic SA nodal automaticity free from the potential
confounding of a constitutive transgenic setting, we ﬁrst exam-
ined the role of AMPK and its modulation using induced murine
pacemaker cell aggregates: terminally differentiated induced
sinoatrial bodies (iSABs). These are highly pure, spontaneously
contracting aggregates consisting substantially of physiologically
functional pacemaker cells derived through forward program-
ming with the nodal inducer TBX3 and Myh6-promoter-based
antibiotic selection of murine pluripotent stem cells27,28.
Sequencing (RNASeq) of iSABs’ gene expression proﬁles, when
compared to control antibiotic-selected cardiac bodies (aCaBs, a
heterogeneous mixture of cardiomyocyte subtypes)27, revealed
increased expression of γ2, but not γ1 transcript, and signiﬁcant
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enrichment of gene ontologies related to AMPK-mediated
and Ca2+-mediated signaling, the type 1A regulatory subunit of
PKA (Prkar1a), striated muscle contraction, fatty acid β-oxida-
tion, and glycogen metabolism (Fig. 3a–d). We then constructed a
weighted gene co-expression network (WGCN) and identiﬁed
Prkag2 in a module (green) of the most highly interconnected
genes (corr= 0.74), including Tbx3, Tbx18, Hcn4, Prkar1a,
Prkar2b, Camk2, Camkk2, Camk4, and Calml4 (Fig. 4a–c).
Comparison of iSABs and aCaBs within the module (1,500 and
200 genes, respectively) conﬁrmed that genes expected to be
co-expressed in endogenous pacemaker cells were found only in
iSABs (Fig. 4d). Hierarchical clustering and multi-dimensional
scaling revealed, in commonality with the SA node transcriptome,
that the Prkag2-containing module represents a major signaling
hub with signiﬁcant connectivity to genes critical to SA node
pacemaker function, including Tbx3, Isl1, and Hcn4 (Fig. 4e–g).
Having identiﬁed signiﬁcant co-expression and correlation
of Prkag2 with known pacemaker-relevant factors in iSABs
(Supplementary Table 4), we tested whether pharmacological
activation of AMPK (Fig. 5a) could lower iSAB-beating
frequency. We observed a reversible, dose–response reduction
in beating rate using both an AMP-mimetic agent (AICAR) and a
small-molecule cyclic benzimidazole derivative (compound 991),
the latter binding speciﬁcally to the β subunit of AMPK to cause
direct allosteric activation29,30 (Fig. 5b–e; Supplementary
Movies 1 and 2).
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Adenovirus-mediated γ2 AMPK gain-of-function reduces SA
cell ﬁring. We next tested whether acute γ2 AMPK-speciﬁc
activation could alter the ﬁring rate of individual fully differ-
entiated mammalian WT SA cells. Given the absence of γ iso-
form-selective AMPK activators, we used adenoviral gene transfer
to acutely overexpress R299Q γ2 (Ad-R299Q γ2), WT γ2
(Ad-WT γ2), or empty vector (Ad-mCherry) in primary SA cells
isolated from WT (adult C57BL/6J) mice31. Whole-cell current-
clamp recordings from cultured C57BL/6J SA cells infected with
Ad-WT γ2 revealed no detectable effect on spontaneous SA cell
beating rate of WT γ2 overexpression (300± 15 bpm) over that of
Ad-mCherry (293± 16 bpm) (Fig. 6a). In contrast, C57BL/6J SA
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cells infected with adenovirus carrying the activating R299Q γ2
mutation displayed a signiﬁcantly slower (>30%) beating rate
(192± 22 bpm, P< 0.01 compared with Ad-mCherry or Ad-WT
γ2, one-way ANOVA; Fig. 6a). We then asked whether these
ﬁndings were consistent in a larger mammalian species with
electrophysiological properties closer to humans. Adult rabbit SA
cells are recognized as excellent models for studying pacemaker
mechanisms and exhibit action potentials with signiﬁcantly closer
ﬁdelity to human than rodent species32. Congruent with our
observations in WT murine SA cells, adenoviral transduction of
stable cultured (72 h) adult rabbit SA cells with Ad-R299Q
γ2 signiﬁcantly reduced spontaneous cell beating rate to ~50% of
that observed with either empty vector or Ad-WT γ2 (P< 0.0001,
one-way ANOVA; Fig. 6b, c).
We next applied a similar gene transfer approach in an attempt
to rescue the reduced beating rate phenotype of SA cells isolated
from homozygous R299Q γ2 mice. Transfection with Ad-WT γ2
vector, through competing out of the mutant allele, completely
restored the reduced ﬁring rate of homozygous R299Q γ2 SA cells
to that of primary C57BL/6J SA cells treated with empty vector
(Fig. 6d).
Collectively, these data establish that (i) acute speciﬁc
activation of γ2 AMPK is sufﬁcient to substantively reduce the
intrinsic ﬁring rate of WT SA cells from two distinct mammalian
species, and (ii) the phenotype of reduced SA cell automaticity
observed in R299Q γ2 mice can be fully reversed postnatally with
short-term gene transfer, arguing against abnormal developmen-
tal SA node patterning as a substantial driver of the phenotype
in vivo.
γ2 AMPK has a physiological role in limiting resting HR. In
view of the ﬁnding of lower sinus rate associated with the acti-
vating R299Q γ2 mutation, we investigated whether tonic γ2
AMPK activation has a physiological role in limiting HR. To
address this, we developed a γ2 knockout model by crossing the
R299Q γ2 line with Sox2cre transgenic mice to allow global
embryonic deletion of the ﬂoxed-mutated exon 7 of Prkag2
(Supplementary Fig. 8a). We conﬁrmed absence of R299Q γ2
transcript, and loss of γ2 AMPK protein and activity, without
signiﬁcant effect on γ1 in these mice (Homo ﬂ Cre+) (Fig. 7a;
Supplementary Fig. 8b–f). We also observed no differences in
gross cardiac structural or functional phenotype compared with
WT Cre+ controls (Supplementary Fig. 8g–j). In contrast to
R299Q γ2 mice, and supporting a physiological role for γ2 AMPK
activation in regulating HR, we found that γ2 loss led to small but
signiﬁcant increases in HR, both in vivo under anesthesia
(Fig. 7b) and during ambulatory telemetric recordings (Supple-
mentary Fig. 9a, b), as well as ex vivo (Fig. 7c). Consistent with
greater intrinsic HR, SA cells from Homo ﬂ Cre+ mice displayed
enhanced automaticity (Fig. 7d, e), but equivalent MDP and cell
capacitance to WT Cre+ (Supplementary Fig. 9c, d). Homo ﬂ Cre
+ mice displayed greater cardiac Hcn1 and Hcn4 expression than
WT Cre+ (Fig. 7f, g); however, we did not identify a statistically
signiﬁcant increase in If density from Homo ﬂ Cre+ isolated SA
cells or changes in fractional activation (Fig. 7h–j). In response to
isoproterenol, SA cells from Homo ﬂ Cre+ mice reached a similar
maximal rate to WT Cre+ but, having starting from a higher
baseline rate, reﬂected a smaller proportional increase from
baseline (Supplementary Fig. 9e). SA cells from both genotypes
exhibited marked reductions in beating rate in response to acet-
ylcholine, and similar mean shifts in the If activation curve fol-
lowing isoproterenol or acetylcholine stimulation (Supplementary
Fig. 9f–h). Measurement of SA cell LCR revealed non-signiﬁcant
trends to greater spontaneous Ca2+ signals in Homo ﬂ Cre+ mice
compared with WT Cre+ (Supplementary Fig. 9i–m).
Loss of γ2 AMPK rescues bradycardia in FNIP1-deﬁcient mice.
Given the relatively subtle increment in sinus HR observed in the
γ2 AMPK knockout, we considered whether the impact of γ2 loss
may be more clearly substantiated in a model characterized by
severe sinus bradycardia that was likely to be AMPK-dependent.
FNIP1 (encoding folliculin-interacting protein 1) is a negative
modulator of AMPK. As such it represents an alternative genetic
strategy to powerfully activate AMPK. FNIP1 homozygous null
mice, through activating AMPK, manifest marked sinus brady-
cardia33. We generated mice deﬁcient in both FNIP1 and
γ2 AMPK by crossing FNIP1 null mice with Sox2cre-driven
γ2 knockout mice and found that loss of γ2 AMPK was sufﬁcient
to rescue FNIP1-deﬁcient bradycardia (Supplementary Fig. 9n).
This observation reinforces the conclusions that AMPK activation
is sufﬁcient to cause sinus bradycardia, and that the HR effect is
directly attributable to the γ2 subunit.
γ2 AMPK is required to develop intrinsic resting bradycardia
of endurance exercise. To determine whether γ2 AMPK has a
broader role in physiological HR regulation, we investigated its
involvement in the widely recognized phenomenon of intrinsic
resting bradycardia, which follows endurance exercise training34.
Exercise is known to activate AMPK in skeletal muscle35,36,
with AMPK in turn having a major role in this tissue’s
adaptive response. We examined the effect of 10 weeks of
voluntary wheel running exercise (Ex), sufﬁcient to activate car-
diac AMPK in resting mice after exercise training (Fig. 8a), on
intrinsic HR in comparison to sedentary controls (S). WT Cre+
and Homo ﬂ Cre+ mice ran comparable distances (6.30±0.51 vs
6.72±0.64 km/24 h, P= 0.58), durations, and average speeds
(Fig. 8b–d). We determined intrinsic HR using ex vivo intact SA
node/atrial preparations37 and found those of Ex WT Cre+ to
display a signiﬁcantly lower spontaneous beating rate than those
from S WT Cre+ mice (364 vs 412 per min, P< 0.01, one-way
ANOVA)—consistent with training-induced intrinsic resting
bradycardia; however, critically, no corresponding training effect
was observed on the intrinsic atrial rate of Homo ﬂ Cre+ mice
(Fig. 8e). We conﬁrmed these ﬁndings in isolated SA cells,
observing reduced automaticity of SA cells from trained WT Cre+
but not from trained Homo ﬂ Cre+ mice (Fig. 8f, g). Consistent
Fig. 4WGCN analysis identiﬁes Prkag2 in a central hub of pacemaker regulating genes. aWeighted gene co-expression network (WGCN) analysis-derived
visualization of the iSAB–aCaB gene network by heat map plot. The heat map shows the topological overlap matrix (TOM) among all genes in the analysis.
Light yellow represents low overlap and darker red represents higher overlap. Blocks along the diagonal are modules. Dendrograms and module color
assignments are shown at the top and along the left side, respectively. b Reﬁnement of the gene modules showing the gene dendrogram (average linkage)
and module color assignment based on dynamic hybrid TOM clustering. c Plot of gene signiﬁcance and intra-modular connectivity illustrating high
correlation within the green module containing Prkag2. d Plot of co-expressed genes in the green module vs gene signiﬁcance subdividing iSABs and aCaBs.
e Further investigation of the relationship and connectivity among the investigated modules illustrated by (upper portion) a hierarchical clustering
dendrogram (average linkage) and (lower portion) eigenvalue adjacency heatmap. fMulti-dimensional scaling plot identifying the green module as a major
signaling hub connecting multiple genes critical to pacemaker functionality. g Heat map illustrating the TOM among genes depicted in e. Each column and
row refers to a single gene. Light yellow represents low overlap and darker red represents higher overlap
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with a previous report38, we observed a clear reduction in SA
whole-cell If density in trained WT Cre+ mice, but no effect of
training on Homo ﬂ Cre+ mice or fractional activation
(Fig. 8h–j). Altogether, these ﬁndings indicate a critical gate-
keeper function for γ2 AMPK activation to enable the intrinsic
bradycardic adaptation to endurance exercise.
Discussion
By characterizing a murine model of a human AMPK-dependent
monogenic bradycardic disorder, we identify a crucial function
for γ2 AMPK, traditionally regarded as a minority AMPK
subunit, as a major SA isoform with a role in regulating SA
node automaticity, and thereby resting HR. This effect is
mediated through inﬂuencing the major signaling networks of
SA cell-autonomous factors regulating pacemaker functionality
(e.g., TBX3 and ISL1) and core sarcolemmal (If) and subcellular
(SR-derived LCRs)-coupled pacemaker mechanisms (Fig. 8k).
We observe an opposite HR phenotype resulting from the loss of
γ2 AMPK, and describe an indispensable role for this energy
sensor in the genesis of intrinsic endurance bradycardia, impli-
cating a non-redundant function for AMPK in mammalian
physiological HR regulation and exercise adaptation. The rela-
tively subtle impact of γ2 AMPK loss at baseline, but its obliga-
tory requirement to develop intrinsic endurance bradycardia,
exemplify AMPK’s primary function as a sensor that is quiescent
at rest but exquisitely responsive to stress.
The R299Q γ2 AMPK gene-targeted mouse model is notable
for its relatively restricted cardiac phenotype—contrasting with
both the uniformly malignant phenotype of transgenic mice
overexpressing mutant human γ2 under a powerful cardiac-
restricted promoter and the full expression of the human
phenotype—speciﬁcally the lack of ventricular pre-excitation or
signiﬁcant LVH. Human PRKAG2 cardiomyopathy is now
recognized to be highly heterogeneous, variably penetrant, and
generally milder than initially reported, an observation typical of
how our understanding of monogenic disorders evolves. We have
previously evaluated a series of 20 patients with the R302Q
PRKAG2 mutation, orthologous to the knock-in mutation carried
by R299Q γ2 knock-in mice. Although 18 of these patients (90%)
had sinus bradycardia, only 2 (10%) had LVH and none had
WPW syndrome. Other clinical reports document the absence of
LVH with this or other PRKAG2 mutations39,40, suggesting that
neither LVH nor pre-excitation are universal features of human
PRKAG2 cardiomyopathy.
The phenotype of transgenic mice often differ from humans. In
addition to recognized functional differences between mice and
humans in terms of allometric scaling, prominent in the cardio-
vascular system and predisposing humans to a more marked
bradycardia per se, an additional difference accounting for the
subtlety of the heterozygote (and indeed homozygote) murine
phenotype is likely to be the relative difference in the cardiac
expression of γ2 in mouse vs human. Use of more penetrant
mutations and an overexpression transgenic approach are likely
to be required to consistently generate the more extreme end of
the phenotypic spectrum in mice. Substantiating these gene
dosage and stoichiometric considerations, other recently gener-
ated gene-targeted γ2 AMPK-mutant mice bearing mutations
with severe biochemical consequences exhibit a remarkably
consistent sinus bradycardia but otherwise subtle cardiac
phenotype41.
AMPK, by virtue of being at the intersection of systemic energy
sensing and caloric regulation9, appears well placed to determine
the established coupling between basal metabolic rate and
HR, and is likely to contribute to various allometric scaling
phenomena, which seem to have empirical validity, albeit
imperfect, over a diverse range of organisms42. Activation of
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γ2 AMPK complexes remodels SA cell gene expression and
electrophysiology, reducing intrinsic resting HR to diminish
myocardial work. A central inference of our study is that, with its
co-option at the metazoan divergence, AMPK has transitioned
from being a purely cell-autonomous regulator of energy charge
to co-ordinating organ-speciﬁc and systemic-caloric accounting.
An example of this broader inﬂuence is its indispensable role in
the regulation of exercise-related changes in HR.
Akin to the similarly highly conserved clock genes that regulate
circadian biology at multiple hierarchical levels, ranging from
cell-autonomous regulation, through entrainment of organ-
speciﬁc time cues at different developmental stages, to the
systemic control of both the persistence and periodicity of
circadian rhythms43, γ2 AMPK regulates the ﬁring frequency of
individual pacemaker cells, thereby gating basal cardiac
contractile rate to ensure medium- to long-term myocardial
energy homeostasis and to inﬂuence whole-mammal energy
expenditure9.
Athletes’ hearts need to remain parsimonious at rest, yet retain
the capacity to perform optimally during vigorous physical
activity. In the context of an increased stroke volume due to
cardiac chamber enlargement, a reduced intrinsic sinus rate—
mediated by intermittent physiologic SA node γ2 AMPK activa-
tion—maintains basal cardiac energy expenditure, yet leaves
substantial chronotropic reserve to accommodate peak activity
demands; loss of γ2 AMPK speciﬁcally abrogates this adaptation.
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In normal physiology, SA node γ2 AMPK activation acts as a
brake to chronically increased HR, mitigating against substantial
cardiac energy expenditure. Conversely, pathological PRKAG2
mutations result in inappropriate and persistent elevation in SA
node γ2 AMPK activity, effectively tonically activating the signal
driving the intrinsic resting bradycardic response to endurance
exercise. In a bidirectional way, therefore, our ﬁndings explain the
deleterious SA node pathology observed in PRKAG2 mutation
carriers and provide a molecular substrate for increasingly
recognized, albeit infrequent, potential long-term sequelae of the
athletic heart, which can include increased risk of symptomatic
SA node disease with need for pacemaker implantation in later
life44. The speciﬁc ability of γ2-containing AMPK complexes to
regulate intrinsic SA node ﬁring and HR raise the possibility that
its selective modulation may hold therapeutic potential in both
states.
Methods
Human R302Q γ2 heterozygous carriers and HR measurement. Assessment of
HR in human subjects was approved by the local Research Ethics Committee (Comitê
de Ética em Pesquisa, Faculdade Ciências Médicas, Minas Gerais, Brazil). All study
subjects provided written informed consent prior to participation. All subjects
underwent genotyping for the R302Q γ2 mutation by PCR ampliﬁcation and ﬂuor-
escent dideoxy sequencing of exon 7 of PRKAG2. Mean HR was obtained from 15
heterozygous R302Q γ2 carriers and 10 genotype-negative sibling controls (41.2± 2.8
vs 38.9± 2.3 years, mean± s.e.m.) using 24-h HR monitors (DMS Cardioscan Pre-
mier 11 Recorder DMS 300-8). In subjects with indwelling permanent pacemakers
(6 R302Q γ2 carriers and no controls), HR was assessed by programming the gen-
erator to VVI mode and measuring the HR after a waiting period of 10min. Anti-
arrhythmic drugs (including β-blockers) were discontinued for at least 5 days before
HR assessment. No subject had atrial ﬁbrillation or was on amiodarone.
Animals. Animal studies were performed in accordance with the 1986 British
Home Ofﬁce Animals Scientiﬁc Procedures Act (UK) incorporating European
Directive 2010/63/EU, the European Directive (86/609/CEE) on the care and
use of laboratory animals, and the Guide for the Care and Use of Laboratory
Animals published by the National Institutes of Health (NIH Publication no.
85–23, revised 1996). All experimental protocols involving animals were
assessed and approved by the local ethical review committee: University of Oxford
Animal Welfare and Ethical Review Body; Animal Welfare committee of the
University of Milan and the Italian Minister of Health (Italian D.lgs 116/92 and D.
Lgs no. 2014/26); the NIH Institutional Animal Care and Use Committee; and the
University of Colorado Denver—Anschutz Medical Campus Institutional Animal
Care and Use Committee (protocol number 84814(06)1E). Experimental animal
work was undertaken blind to genotype.
R299Q γ2 mice have been previously described9. Gene targeting was used to
introduce the R299Q point mutation (equivalent to the human R302Q mutation)
into exon 7 of murine Prkag2. The gene-targeting vector contained a shorter 5′
homology arm (in intron 6 and exon 7) ampliﬁed by PCR from genomic DNA
isolated from 129Sv embryonic stem (ES) cells. The point mutation was introduced
by PCR and the positive selection cassette (neo), ﬂanked by FRT (Flp recombinase
recognition target) sites to enable excision of the neo cassette, was inserted in front
of exon 7. The targeting strategy included insertion of loxP sites within intron 6
upstream and within intron 7 downstream of the mutation, respectively. The
longer 3′ homology arm was obtained from a BAC clone (Sanger Institute,
Cambridge, UK), with a Diphtheria Toxin A (DTA) cassette attached to the 3′
homology arm for negative selection. The homology arms with the mutation were
cloned into a suitable targeting vector in our laboratory; selection cassettes and
genomic DNA were provided by GenOway (Lyon, France). Transfection of 129Sv
embryonic stem (ES) cells, selection, isolation and conﬁrmation of positive clones
by Southern blot analysis, injection of positive clones into C57BL/6 embryos and
in vivo excision of the positive selection cassette were performed by GenOway.
Correct homologous recombination in the positive ES clones was conﬁrmed by
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Southern blot analysis. The presence of the point mutation and the distal loxP site
were validated by sequencing. Positive clones were injected into C57BL/6 embryos.
Highly chimeric males were then bred with Flp-expressing mice and the FRT-
ﬂanked neo cassette deleted, resulting in a ﬂoxed knockin Prkag2 allele. Mice
heterozygous for the R299Q γ2 knockin mutation were initially on a mixed C57BL/
6/129/Ola genetic background and subsequently backcrossed to C57BL/6 for at
least seven generations. R299Q γ2 mice were genotyped by PCR from earnotch
tissue-derived gDNA using primers (Supplementary Table 5) hybridizing either
side of the loxP-FRT sequence in intron 6 to distinguish the WT Prkag2 locus from
the recombined, Flp-excised Prkag2 allele.
Sox2cre transgenic mice45 that had been backcrossed for six generations onto a
C57BL/6 genetic background were crossed with R299Q γ2 mice to achieve global
γ2 deletion via the conditional deletion of the ﬂoxed exon 7 of Prkag2. Mice
deﬁcient in both alleles, representing a global knockout of γ2 (termed Homo
ﬂ Cre+), were compared with control mice hemizygous for the Sox2cre transgene
but wild-type for Prkag2 (termed WT Cre+). Sox2cre γ2 knockout mice were
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genotyped from gDNA using separate PCRs to assess for the R299Q γ2 mutation
(as above), the Sox2cre transgene, and detection of intact and excised exon 7 from
Prkag2 (primer sequences detailed in Supplementary Table 5).
The generation and phenotype of Fnip1 null mutants is as previously
described33 (MGI ID:5806459).
Allelic discrimination. Competitive multiplex PCR of cardiac cDNA for speciﬁc
detection of R299Q γ2 transcript was undertaken using TaqMan MGB ﬂuorogenic
probes speciﬁc for the wild-type (5′-FAM-AGTCCGTGCAGCGC-MGB-3′) or
mutant (5′-VIC-AGTCCAAGCAGCGC-MGB-3′) Prkag2 sequence and common
exon-spanning primers (Supplementary Table 5) ﬂanking the site of the mutation
on exon 7. Primers were designed (Primer Express 3.0) and reactions were
undertaken in accordance with published guidance46 on a StepOne Real-Time PCR
system (Applied Biosystems). Data analysis and visualization were with StepOne
software (v2, Applied Biosystems).
Western blotting. Protein extraction and western blotting were undertaken largely
as previously described47. Brieﬂy, snap-frozen cardiac tissue aliquots were ground
in liquid nitrogen and homogenized in ice-cold buffer comprising 50 mM Tris
base, 250 mM sucrose, 1 mM EDTA, protease and phosphatase inhibitor cocktail
tablets (Roche, West Sussex, UK), 50 mM NaF, 5 mM sodium pyrophosphate,
1 mM dithiothreitol (DTT), 1 mM benzamidine, 0.1 mM phenylmethylsulphonyl
ﬂuoride (PMSF), and 1 mM sodium orthovanadate. Extracts were then centrifuged
at 13,000×g for 15 min at 4 °C. Protein concentration was determined from diluted
aliquots of the soluble fraction by BCA protein assay (Thermo Fisher Scientiﬁc)
with samples then diluted in fresh lysis buffer to yield equivalent ﬁnal protein
concentrations. Lysates were mixed with lithium dodecyl sulfate sample buffer with
DTT (50 mM) (nuPAGE, Invitrogen) and boiled at 95 °C for 5 min. For western
blotting of SA nodes, each sample was pooled from three individual SA nodes and
homogenized and lysed in RIPA buffer (Thermo Fisher Scientiﬁc: 25 mM Tris-HCl
(pH 7.6), 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, 0.1% SDS) sup-
plemented with Halt protease inhibitor cocktail (Thermo Fisher Scientiﬁc), Halt
phosphatase inhibitor cocktail (Thermo Fisher Scientiﬁc) and 1 mM phenylmethyl
sulfonyl ﬂuoride, using a Precellys24 homogenizer (Bertin Instruments) with tissue
homogenization kit at 4 °C. Loading controls were run on the same blot.
SDS-PAGE was undertaken on pre-cast polyacrylamide gels (Nupage 4–12% Bis
Tris gel, Novex, Invitrogen) and transfered onto polyvinylidene diﬂuoride
membranes (Immun-Blot, Bio-Rad) using an electrophoretic transfer cell (Mini
Trans-Blot, Bio-Rad). Blocked membranes (5% milk/tris-buffered saline with
Tween-20, TBST) were incubated with primary antibody, followed by TBST washes
and secondary horseradish peroxidase (HRP)-conjugated antibody detection.
Bands were visualized using ECL reagents (GE Healthcare, Buckinghamshire, UK),
and ﬁlms scanned with subsequent analysis of digital images using ImageJ (NIH).
Uncropped western blots accompanied by the location of molecular weight
markers are shown in Supplementary Fig. 10.
The following antibodies were used: anti-phospho-ACC (#3661) at 1:1,000
working concentration, anti-ACC (#3676) at 1:1,000, anti-phospho-AMPK Thr172
(#2535) at 1:1,000 from Cell Signaling (New England BioLabs, Hertfordshire, UK);
anti-γ1 AMPK (ab32508) at 1:1,000 and anti-β-tubulin (ab6046) at 1:4,000 from
Abcam (Cambridge, UK); anti-γ2 AMPK (sc-19141) at 1:500 and anti-α2 AMPK
(sc-19131) from Santa Cruz Biotechnology (TX, USA); anti-HCN4 (APC-052) at
1:200 from Alomone Labs (Israel); anti-GAPDH (MAB374) at 1:4,000 from Merck
Millipore (Hertfordshire, UK); anti-PLN (ab86930) at 1:2,000, anti-SERCA2
ATPase (ab91032) at 1:2,000, anti-NCX1 (ab177952) at 1:2,000 from Abcam
(Cambridge, MA, USA); anti-CASQ at 1:2,000 (PA1-913), anti-RYR2 at 1:1,000
(MA3-916) and anti-DHPR1 alpha (for LTCC, PA5-23010) at 1:1,000 from
Thermo Fisher Scientiﬁc (Waltham, MA, USA). HRP-conjugated secondary
antibodies used were anti-rabbit IgG (NA934) from GE Healthcare and anti-goat
IgG (ab6741) from Abcam.
AMPK activity assay. Cardiac AMPK activity was measured from immunopre-
cipitated AMPK complexes by SAMS peptide phosphorylation assay essentially as
previously described15. In brief, protein extracts were prepared as per samples for
western blotting, including addition of phosphatase inhibitors. AMPK γ subunit
isoform-speciﬁc antibody was pre-bound to a 50% protein G-sepharose bead slurry
on an orbital shaker (IKA Vibrax VXR) at 4 °C for 2 h. These were then gently
centrifuged and washed in ice-cold PBS/1% triton, followed by a further ice-cold
PBS wash. Tissue lysate was added to pre-bound protein G-antibody mix in ice-
cold 1% triton/HBA buffer (50 mM HEPES, 50 mM sodium ﬂuoride, 5 mM sodium
pyrophosphate, 1 mM EDTA, 10% glycerol [v/v], 1 mM DTT, 1 mM benzamidine,
0.1 mM PMSF, supplemented with a protease inhibitor cocktail tablet (Roche), pH
to 7.4 at room temperature). Immunoprecipitation (IP) was performed on an
orbital shaker at 4 °C for 2–3 h (typically IP 30 μL protein G-Sepharose/antibody
slurry and 250 μg of sample lysate, made up to 500 μL in HBA/1% triton with fresh
protease inhibitors).
In-house antibodies were used for immunoprecipitation of γ2 (rabbit
polyclonal, C-terminus directed) and γ1 (rabbit polyclonal) AMPK. AMPK activity
from immune complexes was determined by measuring the incorporation of [γ-
32P]-ATP into the SAMS synthetic peptide substrate, with/without 0.2 mM AMP,
by scintillation counting (Tri-Carb 2800TR, PerkinElmer, UK).
In vivo cine magnetic resonance imaging. High-resolution in vivo cine MRI was
performed on a cohort of R299Q γ2 mice and WT littermate controls at 2 and
10 months of age, to accurately assess left ventricular volumes, function, and mass
with high spatial resolution. Anesthesia was induced in an anesthetic chamber
using 4% isoﬂurane in 100% oxygen. Electrodes were positioned subcutaneously,
and mice were positioned prone on a dedicated mouse cradle and maintained at
1.5–2% isoﬂurane at 2 L/min oxygen ﬂow. Temperature was maintained at ~37 °C
using a homeostatically controlled warm air blanket. Cardiac and respiratory sig-
nals were continuously monitored and used for combined ECG gating and
respiratory gating. Eyes were protected with a petroleum-based ophthalmic oint-
ment. Cine MRI experiments were carried out using a horizontal 210 mm bore
9.4 T magnet with VNMRS DirectDrive console and 60 mm i.d. 1,000 mT/m
actively shielded gradient system (Agilent Technologies, USA). A 33 mm internal
diameter, quadrature-driven birdcage resonator (Rapid Biomedical, Germany) was
used for signal transmission/reception. Cine imaging was carried out as described
previously48. Multi-frame left ventricular-short axis slices were acquired (7–10
contiguous slices, 1 mm thickness, 18–32 frames per cardiac cycle) covering apex to
base. Images were reconstructed off-line as TIFF ﬁles using custom-written soft-
ware. End-diastolic and end-systolic frames were selected for each slice according
to maximal and minimal ventricular cavity size and semi-automated image seg-
mentation performed by a single operator using AMIRA software (Visage Imaging)
blind to mouse ID/genotype.
In vivo cardiac 31P magnetic resonance spectroscopy. MR spectroscopy
experiments were carried out using a 9.4 T magnet as above with 120 mm i.d.
600 mT/m actively shielded gradient system (Agilent Technologies, USA). An
actively decoupled variable tune/match 14 mm diameter31P surface coil was pur-
pose built in-house and used in conjunction with a double tuned 1H/31P volume
resonator (Rapid Biomedical, Germany) for acquisition. Animals were prepared as
described above. Shimming and scouting were carried out using the1H channel of
the volume coil. A removable 4 mm point sphere ﬁlled with 15M H3PO4 was
placed outside the animal cradle to allow for accurate and rapid pulse calibration
using an unlocalized pulse-acquire experiment. 2D acquisition weighted (Hanning)
CSI (chemical shift imaging) data were acquired for WT, heterozygote R299Q γ2,
and homozygote R299Q γ2 male mice aged ~10 weeks (n= 7, 18, 9, respectively)
from a 5mm thick mid-ventricular short axis slice (in-plane voxel size of 2.31 ×
2.31 mm, 13 × 13 PE steps, 30 × 30 mm FOV, 5 mm slice thickness, 8191 scans,
TE=0.87 ms). Acquisitions were cardiac gated and a TR of ~250 ms (two cardiac
cycles) was used with a 30° ﬂip angle. Total scan time for the experiment was
~35 min. Multi-slice 1H anatomical images covering the ﬁeld of view of the CSI
experiment were acquired to conﬁrm the position and tissue content of the CSI
voxels. Fully sampled data were zeroﬁlled to 64 × 64 PE steps, and reconstructed as
described previously49.
For each mouse, a 3 × 3 grid of spectra from voxels located at the septum of the
heart was ﬁtted using a Voigt lineshape (in-house software), and the PCr, γ-ATP,
and 2,3-diphosphoglycerate (DPG) signal amplitudes estimated. The spectrum
Fig. 8 γ2 AMPK is critically required for the intrinsic bradycardic adaptation to endurance exercise. a Results of western blot analysis of α AMPK Thr172
phosphorylation in whole heart tissue from sedentary (S) and exercised (Ex, 10 weeks of voluntary wheel running) WT Cre+ mice (n= 8–10). b–d Average
daily distance (b), time (c), and speed (d) of voluntary wheel running during a 10–week training period of WT Cre+ and Homo ﬂ Cre+ mice (n= 17–26).
e Spontaneous beating rate of isolated intact SA node/atrial preparations from S and Ex WT Cre+ and Homo ﬂ Cre+ mice (n= 10–22). f Representative
action potentials recorded from isolated SA cells. gMean beating rate of isolated SA cells from S and Ex groups (n= 12–27 cells). h Representative SA cell
If traces during steps to −125 mV. i Mean fully activated I/V curves recorded in SA cells. Linear data ﬁtting yielded statistically signiﬁcant differences
(P< 0.0001) in If slope conductance of SA cells from exercised WT Cre+ mice only, with conductance values of 481 (S WT Cre+), 447 (S Homo ﬂ Cre+),
272 (Ex WT Cre+) and 447 pS/pF (Ex Homo ﬂ Cre+) (n= 6–14 cells/4–8 mice per group). j Mean voltage-dependence of If activation of SA cells from
both S and Ex groups (n= 6–15). k Schematic depicting the central function of SA cell γ2 AMPK in overall cardiac energy accounting. a–d Student’s t-test
was performed; e, g, one-way ANOVA followed by (e) Holm–Sidak’s multiple comparisons test or (g) Fisher’s least signiﬁcant difference test was
performed. *P< 0.05, **P< 0.01, ξP< 0.0001 for both Ex WT Cre+ vs S Homo ﬂ Cre+ and Ex WT Cre+ vs Ex Homo ﬂ Cre+ comparisons. a–e, g Data are
shown as means± s.e.m.
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with the lowest γ-ATP/DPG ratio was selected as the nominal blood spectrum, and
its PCr and γ-ATP amplitudes, normalized to DPG amplitude, were subtracted
from those of the remaining eight myocardial spectra. Finally, T1 saturation
correction for residual PCr and γ-ATP amplitudes was carried out using the mean
TR for the CSI experiment, and published T1 values50. The mean PCr/γ-ATP ratio
was then calculated for the myocardium.
Cardiac histology. Hearts were rinsed in ice-cold PBS and immerse-ﬁxed in 10%
neutral buffered formalin (VWR, Leicestershire, UK) for 24 h, then processed in an
automated tissue processor (Bavimed Histomaster, Germany) overnight. Cross-
sections (5–7 µm) were obtained using a microtome (Leica RM 2155), spread onto
polysine-coated glass slides (VWR), and allowed to dry. Sections were stained with
hematoxylin and eosin (Sigma-Aldrich, Dorset, UK), periodic acid-Schiff (Sigma-
Aldrich) or Picrosirius red (Polysciences, Germany). Images were acquired with a
Nikon light microscope (Nikon Eclipse TE2000U) coupled to a digital camera
(Nikon Digital Sight DS-5M).
Transmission electron microscopy. Hearts were extracted, cut ﬁnely into small
(~1 mm3) blocks and ﬁxed overnight in 4% glutaraldehyde in 100 mM phosphate
buffer, followed by post-ﬁxation in 2% osmium tetroxide in 100 mM phosphate
buffer. Specimens then underwent en bloc treatment with uranyl acetate, dehy-
dration in ethanol, and transferred to propylene oxide, prior to embedding. Ultra-
thin sections (50–70 nm) were cut and stained with uranyl acetate and lead citrate,
and examined in a JEOL 1200EX electron microscope.
Biochemical glycogen content. Cardiac glycogen was quantiﬁed in R299Q γ2 and
WT mice aged 12 months essentially as described15. In brief, snap-frozen tissue
samples ground under dry ice were homogenized in lysis buffer (50 mM Tris,
0.25M mannitol, 1 mM DTT, 0.1 mM PMSF adjusted to pH 7.4 and supplemented
with protease inhibitor tablets [Roche]) and sonicated prior to syringe-and-needle
homogenization. A total of 2 M KOH at 70 °C was used to solubilize glycogen
followed by amyloglucosidase digestion overnight to release glucose. Glucose
content was then determined using an enzyme coupled assay (Roche) to generate
glucose-6-phosphate (G6P) by hexokinase, followed by oxidation of G6P by G6P
dehydrogenase in the presence of NADP+, with spectrophotometric measurement
of NADPH after 30 min.
Cardiac qPCR. RNA extraction, cDNA synthesis, and RT-PCR were performed as
previously described47. qRT-PCR using inventoried TaqMan gene expression
assays was used to determine relative gene expression of the following: γ2 and γ1
AMPK in wild-type C57BL/6 murine SA nodes and LVs (Prkag2,
Mm00513977_m1; Prkag1, Mm00450298_g1); and cardiac expression of Slc2a1
(Mm00441480_m1), Slc2a4 (Mm00436615_m1), Gyg (Mm00516516_m1), and
Pygm (Mm00478582_m1) in R299Q γ2 and WT mice. Relative expression of the
target gene was quantiﬁed using the 2−ΔΔCt method using Actb (Mm00607939_s1)
as the endogenous control (where ΔCt is the difference in cycle threshold value
between the target transcript and the endogenous control). Samples were analyzed
in at least duplicate, and samples minus reverse transcriptase enzyme and samples
minus cDNA template were used as negative controls (to exclude gDNA con-
tamination or reagent cross-contamination, respectively) and checked to ensure
they failed to reach threshold by 40 cycles.
SA node histology. SA nodes were harvested using an operating microscope and
12 consecutive 5 μm parafﬁn-embedded sections obtained. SA node sections were
stained with the following: Masson’s Trichrome (Masson’s Trichrome stain kit,
American MasterTech, Lodi, CA); reticulum plus picric red stains to determine
collagen and outline atrial myocytes (Chandler’s precision reticulum stain kit,
American MasterTech); and Periodic acid-Schiff (PAS kit, American MasterTech).
High-resolution digital images of cross-sections were acquired using a Leica
microscope. Morphometric evaluation was performed using a computerized ima-
ging analysis system (Metamorph, University Imaging) blind to genotype
according to a modiﬁed prior method51. Quantiﬁcation of PAS-stained areas and
cells (clusters of small, round, homogeneous PAS-positive granular structures) was
taken from images at ×400 magniﬁcation.
Invasive electrophysiology. Conduction parameters were assessed in 3-month-
old R299Q γ2 and WT littermate controls based on modiﬁcations of a published
EPS protocol for mice52. Under 1.5% isoﬂurane anesthesia, a 1.1F electrophysiology
catheter (EPR-801, Millar Instruments) was introduced into the right atrium and
ventricle via the right internal jugular vein. High-ﬁdelity intracardiac electrograms
were ﬁltered at 0.5–500 Hz and continuously recorded using PowerLab and Lab-
Chart software (ADInstruments, Oxford). After obtaining a baseline surface ECG,
programmed stimulation protocols were performed as described53 using a pacing
stimulator with output set at twice diastolic threshold (s88 Grass stimulator, Grass
technologies, USA). Sinus cycle length (SCL) and sinus node recovery time (SNRT)
were determined by delivering an atrial pacing train at a cycle length of 100 ms for
15 s. SNRT was calculated as the maximum interval from the last-paced atrial
complex to the ﬁrst spontaneous complex after cessation of pacing. All
measurements were repeated in triplicate. Atrioventricular (AV) Wenckebach cycle
length (AVW) and AV 2:1 cycle length were determined using burst atrial pacing
by progressively reducing pacing cycle length from baseline in decrements of 10 ms
(incremental atrial pacing) until 1:1 AV conduction was reliably lost (Wenckebach
cycle length), or resulted in failure of conduction of every other pacing stimulus to
the ventricle (2:1 cycle length). AV nodal effective refractory period (AVNERP)
was determined using programmed atrial extrastimulus pacing with an eight sti-
muli atrial drive train (S1) delivered at 100 ms, followed by a single premature
stimulus (S2) progressively decremented until ventricular conduction was lost.
AVNERP was deﬁned as the longest S1–S2 coupling interval where S2 failed to
capture the ventricle. Right atrial programmed electrical stimulation was used in an
attempt to induce an atrioventricular re-entrant tachycardia (AVRT) as evidence
for the existence of an accessory pathway. An atrial double extrastimulus technique
was used with an eight stimuli primary drive train (S1) delivered at a ﬁxed cycle
length of 100 ms, followed by premature stimuli (S2 and S3) coupled at 80 ms and
decremented to refractoriness. Further provocation for AVRT included atrial-burst
pacing at ﬁxed cycle length, including following β-adrenoceptor stimulation by
isoproterenol administration (1 ng/g IV). All recordings were analyzed off-line,
blind to genotype, using LabChart software (ADInstruments).
ECG biotelemetry. Data were recorded using biotelemetry sensors (HDX-11 or
ETA-F20 from Data Sciences International, St. Paul, MN) recorded at 1000 Hz. All
recordings were taken during the light cycle with mice held in a standard 12 h
light–dark cycle with constant temperature and humidity.
Ex vivo cardiac perfusion and HR. Ex vivo cardiac perfusion was performed as
previously described47 with minor modiﬁcations. Brieﬂy, following pentobarbitone
anesthesia (140 mg/kg IP) and systemic heparinization (150 IU), hearts were
removed, cannulated, and retrogradely perfused at 37 °C in Langendorff mode at a
constant perfusion pressure of 80 mmHg with a modiﬁed Krebs–Henseleit buffer
that contained the following (in mmol/L): NaCl, 118.5; NaHCO3, 25; KCl, 4.75;
KH2PO4, 1.18; MgSO4, 1.19; CaCl2, 1.41; D-glucose, 11; pyruvate, 5; pH 7.4;
saturated with 95% O2 and 5% CO2. Inclusion criteria used were: time interval to
aortic cannulation of under 3 min and absence of persistent arrhythmias during
stabilization. For measurement of AMPK activity in the context of preserved cel-
lular energetic status, hearts were freeze-clamped after a 25 min stabilization period
of perfusion as previously described21. For ex vivo HR, we used Krebs–Henseleit
buffer without supplemental pyruvate. A ﬂuid-ﬁlled polyvinylchloride ﬁlm balloon
was introduced into the LV and connected to a pressure transducer (ADInstru-
ments). The reading was digitally processed to provide a ventricular pressure
recording from which HR was subsequently derived blinded to genotype. Intrinsic
HR was recorded as the average measured rate over 30 s, 5 min after cannulation.
SA node isolation and RNA extraction. The heart with lungs was quickly
removed and immersed at 4 °C to wash out the blood in an external solution that
contained the following (in mmol/L): NaCl, 137; KCl, 4.9; NaH2PO4, 1.2; glucose,
15; HEPES, 20; MgCl2, 1; pH 7.4. The heart–lung block was pinned to the tissue
bath to excise the right atrium (RA) and SA node under a stereomicroscope. The
tissue bath was perfused with the external solution at a rate of 10 mL/min. After
removal of both ventricles and the left atrium, the RA was opened to expose the
crista terminalis, the intercaval area and the interatrial septum. This preparation
was pinned by small stainless steel pins to the chamber with the endocardial side
exposed up and trimmed carefully to extract the SA node region correctly. The SA
node region was delimited by the borders of the crista terminalis, the interatrial
septum, superior and inferior vena cava. All tissues were snap-frozen in liquid
nitrogen and stored at −80 °C for subsequent RNA extraction. Four mouse SA node
tissues were pooled and processed together for the extraction of one sample of total
RNA. RNA was extracted with an RNeasy Mini Kit (Qiagen) using DNase on-
column digestion according to the manufacturer’s protocol.
SA node gene expression proﬁling and microarray analysis. R299Q γ2 and WT
littermate controls (four homozygote R299Q γ2, four heterozygote R299Q γ2, and
three WT) were hybridized to Illumina MouseRef-8 v2 bead chips. BeadArrays
were scanned by the Illumina BeadStation 500X. All data were log2-transformed
and normalized by Robust Spline Normalization using the lumi software package
in Bioconductor54. Overall, 18,185 nucleotide probes were ﬁltered from 25,697 total
using an Illumina detection P value of α= 0.05. Signiﬁcant genes were selected by a
one-way ANOVA or t-test (FDR = 0.05) for further analysis. GSEA software55 was
used to select differentially expressed (DE) genes by calculating out a “score” using
the Kolmogorov–Smirnov (KS) test. The score indicates how a gene relates with
genotype, where positive values relate to upregulation and negative values relate to
downregulation. Only transcripts with a KS score > |0.15| were considered DE.
Transcripts demonstrating greater than 1.2-fold change in expression were pro-
cessed using Ingenuity Pathway Analysis software (Ingenuity Systems Inc., CA,
USA) to identify networks and canonical pathways overrepresented in enriched
genes.
SA node microarray validation. Total RNA (850 ng) were used for cDNA pre-
paration in a 40 µL reaction volume with MMLV reverse transcriptase (RT, Life
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Technologies, CA, USA) with random hexamers. All cDNA synthesis reactions
were accompanied by no template controls for the detection of possible con-
tamination and no RT controls to detect potential genomic DNA. qRT-PCR was
performed using an ABI Prism 7900HT Sequence Detection System (Applied
Biosystems) with a 384-well platform. Reactions were performed with FastStart
Universal SYBR Green Master mix with ROX (Roche) using manufacturer
recommended conditions. Forward and reverse primers used are detailed in Sup-
plementary Table 5.
Preliminary reactions were run to determine ampliﬁcation efﬁciency. The size
of the amplicon and its speciﬁcity were assessed by agarose gel analysis and a post-
ampliﬁcation dissociation curve, respectively. Each well contained 0.5 µL of cDNA
solution and 10 µL of reaction mixture. Samples were assessed in quadruplicate and
relative expression calculated using the 2−ΔΔCt method using Hprt as endogenous
control (where ΔCt is the difference in cycle threshold value between the target
transcript and the endogenous control). Statistical analysis was undertaken using a
one-tailed Student’s t-test.
Murine SA cell electrophysiology and If measurement. Hearts were extracted,
and the SA node region dissected and used for isolation of SA cells by an enzymatic
and mechanical dissociation procedure as previously described56. Brieﬂy, hearts
were rapidly removed and placed in a pre-warmed (37 °C) Tyrode solution (in
mmol/L: NaCl, 140; KCl, 5.4; CaCl2, 1.8; MgCl2, 1; D-glucose, 5.5; HEPES-NaOH,
5; pH 7.4) containing 1,000 U heparin. The SA node region was surgically exposed,
isolated, and cut into small strips, which were placed in an enzymatic solution
containing the following: collagenase (224 U/ml, Worthington), elastase (1.42 U/
mL, Sigma-Aldrich), and protease (0.45 U/mL, Sigma-Aldrich) to loosen inter-
cellular connections. The enzymatic solution was then removed and SA strips
placed in a high-K+, low-Na+, Ca2+, and Mg2+-free solution. Cells were then fully
dispersed and separated by manual agitation of SA strips using a glass pipette with
a small tip (~2–3 mm diameter). Cells were ﬁnally reacclimatized to physiological
concentrations of NaCl, KCl, MgCl2, and CaCl2 by adding the necessary amounts
of a solution containing 1.8 mM CaCl2 and 10 mM NaCl, and normal Tyrode with
BSA 1mg/mL. Isolated single cells were kept at 4 °C for the day of the experiment
and patch-clamp experiments were performed in the whole-cell conﬁguration at
35± 0.5 °C. The pipette solution contained (in mmol/L): K-aspartate, 130; NaCl,
10; EGTA-KOH, 5; CaCl2, 2; MgCl2, 2; ATP (Na-salt), 2; creatine phosphate, 5;
GTP (Na-salt), 0.1; pH 7.2. Action potentials were recorded from spontaneously
beating SA node myocytes or small uniformly beating aggregates of pacing cells
(2–5 cells) superfused with normal Tyrode solution and the rate and MDP values
measured with customized software. If was recorded from single cells superfused
with Tyrode solution containing BaCl2 (1 mmol/L) and MnCl2 (2 mmol/L). Steady-
state current amplitudes were calculated at the end of a 3 s step to −125 mV
(holding potential, −35 mV). A two-step protocol was used to assess the voltage
dependence of the current, with a ﬁrst step to a test voltage in the range −35/
−135 mV and a second step to −120 mV. Test step durations varied from 10 s at
−35 mV to 5/7.5 s at −135 mV to allow full current activation at each voltage. The
Boltzmann distribution (y= 1/(1+exp((V−V1/2)/s): V, voltage; y, fractional activa-
tion; V1/2, half-activation voltage; s, inverse-slope factor) was used to ﬁt experi-
mental data-points. Fully activated If current–voltage (I/V) relationships were
obtained according to a previously published protocol57. Shifts of the If activation
curve induced by isoproterenol (30 nM) or acetylcholine (30 nM) were measured
near the midpoint of the activation curve (−75 mV) as previously reported58.
Local Ca2+ releases in permeabilized SA node cells. SA node pacemaker cells
were isolated from SA node tissue of 3-month-old mice and permeabilized using
0.01% saponin. After saponin washout, the solution was changed to a recording
solution that contained the following (in mmol/L): ﬂuo-4 pentapotassium salt, 0.03;
CaCl2, 0.099 (free [Ca2+] ∼ 50 nM); C4H6NO4K (DL-aspartic acid potassium salt),
100; KCl, 25; NaCl, 10; MgATP, 3; MgCl2, 0.81 (~1 mM free Mg2+); Hepes, 20;
EGTA, 0.5; phosphocreatine, 10; creatine phosphokinase (5 U/mL); pH 7.2. The
cytosolic free Ca2+ at given total Ca2+, Mg2+, ATP, and EGTA concentrations was
calculated using a computer program (WinMAXC 2.50, Stanford University).
Spontaneous characteristics of Local Ca2+ Releases (LCR) were measured by
confocal microscopy in ﬁxed free [Ca2+] as previously described59. The amplitude
of individual LCRs was expressed as peak value (F) normalized to minimal
ﬂuorescence (F0). LCR spatial size (FWHM) was indexed as the full width at half-
maximum amplitude. LCR duration (FDHM) was characterized as the full duration
at half-maximum amplitude. The number of LCRs was normalized per 100 µm of
the line-scan image and during a 1 s time interval. The Ca2+ signal of an individual
LCR was estimated as previously described59. M= FWHM× FDHM× (ΔCa2+,
nmol/L)/2. The Ca2+ signal of the LCR ensemble was estimated by integrating the
Ca2+ signal produced by each LCR and normalized per 100 µm of the line-scan
image and during a 1 s time interval59.
SA cell immunohistochemistry. To localize the expression of HCN4 in situ, 5 µm
parafﬁn-embedded SA node sections were stained with a monoclonal anti-HCN4
antibody (1:800, ab85023, Abcam) employing the Dako EnVision+ System-HRP
(DAB) kit (#K4006, CA, USA). The 3,3′-diaminobenzidine (DAB) substrate-
chromogen reaction (brown color) was visualized using a Leica microscope. High-
resolution/high-magniﬁcation (×400) digital images of representative cross-
sections of SA node bodies were acquired using a computerized imaging analysis
system (Metamorph, University Imaging).
To visualize the expression of phospholamban (PLN), freshly isolated SA cells
were ﬁxed, blocked, and permeabilized using the Image-iT Fixation/
Permeabilisation kit (Life Technologies). Immunohistochemistry was undertaken
using 1:200 primary mouse monoclonal anti-PLN (A010-14, Badrilla, Leeds, UK)
and 1:1000 secondary Alexa Fluor 488 donkey anti-mouse (A212202, Life
Technologies) antibodies. Nuclear counterstaining was with 4′,6-diamidino-2-
phenylindole (DAPI). Fluorescence images were visualized using a Zeiss LSM710
confocal scanning microscope with a 63 × 1.4 NA immersion oil objective and
images recorded with ZEN 2 acquisition software (Zeiss, Germany).
iSAB and aCaB generation. Generation of iSABs (induced sinoatrial bodies) and
aCaBs (antibiotic-selected cardiac bodies) was performed as previously descri-
bed27,28. In brief, murine cell lines27 were used to generate iSABs and aCaBs and
grown in high-glucose DMEM with stable glutamine (GIBCO) containing the
following: 10% FBS Superior (Biochrom), 100 µM non-essential amino acids
(GIBCO), 1% penicillin/streptomycin (GIBCO), and 100 μM β-mercaptoethanol
(Sigma) in the presence of 1,000 U/mL of leukemia inhibitory factor (LIF, Milli-
pore). Differentiation was performed by hanging drop culture for 2 days using
1,000 cells as starting material for one EB (embryoid body) in Iscove’s basal
medium (Biochrom) containing the following: 10% FBS (Biochrom), 100 µM non-
essential amino acids (GIBCO), 1% penicillin/streptomycin (GIBCO), and 450 µM
1-thioglycerol. Cells were differentiated for an additional 4 days in suspension
culture, and at day 6 of differentiation 15 EBs were seeded onto one well of a
24-well-plate. At day 8 post-seeding, antibiotic selection was initiated using
400 µg/mL G418 (Biochrom). Four days thereafter, aCaBs and iSABs were isolated
by treatment with 6,000 U/mL Collagenase IV (GIBCO) for 30 min. Single cells
were obtained by further dissociation of the bodies using 100% Accutase (Affy-
metrix) for 15 min. Potential mycoplasma contamination was routinely controlled
for twice a week using the PCR based MycoSPY kit system (Biontex). The iSABs
were generated according to Rimmbach et al.28
ELISA assessment of α AMPK Thr172 phosphorylation was performed using
the PathScan Phospho-AMPKα (Thr172) Sandwich ELISA Kit (Cell Signaling
Technology Inc., USA) according to the manufacturer’s protocol. For this, 60 µg/
mL protein was isolated from iSABs at 0, 15 and 60 min following treatment with
100 µM Compound 991, 0.5 mM AICAR or control and subjected to ELISA.
Experiments were performed with four biological replicates, each of which was
analyzed using two technical replicates.
iSAB RNA sequencing and data analysis. For library generation and sequencing,
cultured adherent cells were drained from the culture medium, washed, and
directly lysed by addition of lysis buffer60. A total of 1 µL of this lysate was used for
cDNA synthesis and ampliﬁcation with the SMARTer kit (Clontech, Mountain
View CA, USA) according to the manufacturer’s instructions. In brief, cDNA
synthesis was initiated by annealing a polyA-speciﬁc primer and adding a reverse
transcriptase with terminal transferase activity. The newly synthesized ﬁrst strand
cDNA was then tailed ﬁrst with a homopolymer stretch by terminal transferase and
then with a speciﬁc ampliﬁcation tag by template switching. The resulting double-
tagged cDNA was ampliﬁed by PCR, fragmented by sonication (Bioruptor, Diag-
enode, Liege, Belgium; 25 cycles 30 s on/30 s off) and converted to barcoded
Illumina sequencing libraries using the NEBnext Ultra DNA library preparation kit
(New England BioLabs, MA, USA). After PCR enrichment the libraries were
puriﬁed with AmpureXP magnetic beads (Beckman-Coulter, CA, USA) and
quantiﬁed on a Bioanalyzer 2100 (Agilent, CA, USA). Libraries were pooled at
equimolar amounts and sequenced on an Illumina GenomeAnalyzer IIx in single-
read mode with a read-length of 78 nucleotides and a depth of 21–32 million raw
reads per replicate.
We performed adapter clipping and quality trimming procedures for data pre-
processing61. We aligned the reads to the mm9 genome with the aid of TopHat262.
Differential expression analysis was performed using Cufﬂinks2/Cuffdiff263,64. We
considered genes with >2-fold change and a q value< 0.05 as signiﬁcantly
differentially expressed. The gene annotation, including functional annotation
clustering and functional classiﬁcation, was performed with DAVID and based on
gene ontology terms65. We used our openly available RNA sequencing pipeline
(TRAPLINE) for data analysis66.
WGCN analysis. Weighted gene coexpression network analysis was performed by
applying the R package “WGCNA” to RNASeq data67. We ﬁrst constructed the
topological overlap matrix (TOM) of all investigated transcripts (~30,000) using
the soft thresholding method. We calculated the eigenvalues of the transcripts and
evaluated adjacency based on distance. We subjected transcripts to hierarchical
clustering (average linkage) and assigned transcripts with the dynamic hybrid
method into groups. We computed connectivity based on the interaction partners
(k) and evaluated gene signiﬁcance, representing module membership. Finally, we
computed a network screening analysis using the WGCNA package to distinguish
between true positive results and noise.
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Gene ontology analysis. Networks were built using several applications in
Cytoscape68. ClueGo was used to visualize and cluster the gene annotation terms
into groups69. The KEGG and Panther pathway databases were used to obtain
speciﬁc gene annotations70–72. The network interaction graph was built with the
aid of enhanced Graphics and integrates fold change values (http://apps.cytoscape.
org/apps/enhancedGraphics). Interactions between mRNAs were identiﬁed with
“Agilent literature search” and are based on validated publications (http://apps.
cytoscape.org/apps/agilentliteraturesearch).
Isolation and culture of primary murine SA cells. SA cells were isolated as
previously described31 from 2–4-month-old male C57BL/6J (Jackson Laboratories)
or homozygous R299Q γ2 mice. Mice were anesthetized by inhalation of isoﬂurane
prior to killing. Hearts were rapidly excised, the ventricles and left atria removed,
and the SA node dissected from the remaining right atrial tissue at 35 °C in a
heparinized Tyrode’s solution, which consisted of the following (in mM): 140 KCl,
5.4 KCl, 1.2 KH2PO4, 5 HEPES, 5.55 D-Glucose, 1 MgCl2, 1.8 CaCl2, with a pH
adjusted to 7.4 with NaOH. SA node tissue was enzymatically digested by 4.75 U
elastase (Worthington Biochemical), and 3.75 mg Liberase TM (Roche) for 15 min
at 35 °C in a modiﬁed Tyrode’s solution, containing (in mM) 140 NaCl, 5.4 KCl,
1.2 KH2PO4, 5 HEPES, 18.5 D-glucose, 0.066 CaCl2, 50 taurine, 1 mg/mL bovine
serum albumin (BSA), with pH adjusted to 6.9 with NaOH. Following digestion,
tissue was transferred to a modiﬁed KB solution (in mM: 100 potassium glutamate,
10 potassium aspartate, 25 KCl, 10 KH2PO4, 2 MgSO4, 20 taurine, 5 creatine, 0.5
EGTA, 20 glucose, 5 HEPES, and 0.1% BSA; pH adjusted to 7.2 with KOH) at 35 °C
and SA cells dissociated by mechanical trituration with a ﬁre-polished glass pipette.
The calcium concentration of the cell suspension was gradually increased to
1.8 mM.
Following calcium re-adaptation, SA cells were pelleted (at ~3000 RPM) and the
supernatant carefully aspirated. For plating, SA cells were suspended in plating
media, which contained Media199 (#M4530, Sigma) supplemented with 10 mM
2,3-butanedione monoxime (BDM), 10,000 U penicillin/10 mg streptomycin, and
5% (v/v) FBS. Glass coverslips were prepared by coating 12-mm diameter
coverslips for ~1 h at 37 °C with 100 ng/mL mouse laminin (BD Biosciences, San
Jose, CA, USA) diluted in phosphate-buffered saline (PBS). Excess laminin/
Tyrode’s was removed immediately before cell plating. SA cells were plated such
that the cells from one mouse SA node were seeded onto one 12-mm round
coverslip. SA cells were allowed to settle and adhere to the coverslip for 4–6 h at 37
°C in an atmosphere of 95% air/5% CO2 before changing the media to culture
media, which consisted of Media199 supplemented with 0.1 mg/mL bovine serum
albumin (BSA; Sigma), 10 mM BDM, 10 μg/mL insulin, 5.5 μg/mL transferrin,
5 ng/mL selenium (ITS; Sigma), and 10,000 U penicillin/10 mg streptomycin.
Culture media was exchanged every 24 h.
Adenoviral transduction of primary murine SA cell cultures. SA cells on each
coverslip were counted immediately prior to viral delivery. Adenoviral infections
were performed on the same day as isolation in serum-free culture media at a
multiplicity of infection (MOI) of 100 (100 infectious agents per target cell) as
described31. Adenoviruses Ad-mCherry, Ad-mCherry-mPrkag2 (WT)-FLAG (i.e.
Ad-WT γ2) and Ad-mCherry-mPrkag2(R299Q)-FLAG (i.e. Ad-R299Q γ2) were
constructed, ampliﬁed and puriﬁed by Vector BioLabs (Philadelphia, PA, USA). SA
cells were incubated with virus-containing media overnight (~12–14 h) and
replaced with fresh culture media the following morning.
A fragment of a coverslip bearing SA cells was transferred to the recording
chamber of an inverted microscope. During all experiments, cells were constantly
perfused (1–2 mL/min) with extracellular solution at 35± 1 °C. SA cells were
identiﬁed by their characteristic morphology, small size, and generation of
spontaneous action potentials. Patch clamp recordings used borosilicate glass
pipettes with resistances of 1.5–3MΩ. Data were acquired at 5–20 kHz and low-
pass ﬁltered at 1 kHz using an Axopatch 1D or 200B ampliﬁer, Digidata 1322a or
1440a A/D converter and ClampEx software (Molecular Devices). The fast
component of pipette capacitance was minimized in all recordings using the patch-
clamp ampliﬁer. Membrane capacitance was estimated from responses to 10 mV
test pulses using the membrane test function in ClampEx. Spontaneous beating
rates were recorded from SA cells in the whole-cell conﬁguration in current-clamp
mode without injected current. Cells were constantly perfused with normal
Tyrode’s solution (in mM: 140 NaCl, 5.4 KCl, 1.2 KH2PO4, 5 HEPES, 5.55 glucose,
1 MgCl2, 1.8 CaCl2; pH adjusted to 7.4 with NaOH). The intracellular (pipette)
solution was composed of the following (in mM): 140 K-Aspartate, 10 HEPES, 1.8
MgCl2, 10 NaCl, 0.1 EGTA, 0.02 CaCl2; pH adjusted to 7.2 with KOH. Recordings
were only made from infected cells, identiﬁed by mCherry ﬂuorescence, in each
culture. Viral transduction efﬁciency was essentially 100%, with no difference in
efﬁciency between the different constructs and with each cell in the dataset
infected. Beating rates were determined from averages of the instantaneous
frequency during 15–30 s recording windows in the presence of 1 nM Isoproterenol
(ISO; Calbiochem) in the bath.
Primary rabbit SA cell culture and adenoviral transduction. Adult rabbits were
treated in accordance with the NIH Guide for the Care and Use of Laboratory
Animals (animal protocol number: 034LCS2016). Single, spindle-shaped,
spontaneously beating SA cells were isolated from the hearts of New Zealand
rabbits (Charles River Laboratories, Wilmington, MA, USA) as described pre-
viously73. To generate cultured SA cells (c-SANC), freshly isolated SA cells were
diluted 20 times with serum-containing medium, and centrifuged for 10 min at
500 rpm. Following aspiration of the supernatant, cells were plated at a density of
0.5×104 per cm2 on laminin pre-coated (20 µg/mL, Sigma-Aldrich) glass-bottom
dishes for culture. The serum-containing medium74 contained a 73% salt solution
(in mmol/L: NaCl 116, KCl 5.4, MgCl2 0.8, NaH2PO4 0.9, D-Glucose 5.6, Hepes 20,
CaCl2 1.8, NaHCO3 26), 20% M199 (Sigma-Aldrich), in the presence of (in mmol/
L) creatine 5, taurine 5, insulin–transferrin–selenium-X 0.1%, 4% fetal bovine
serum, 2% horse serum, and 1% penicillin and streptomycin (pH= 7.4 at 37 °C).
Cells were incubated in serum-containing medium for the ﬁrst 24 h, and then
cultured in serum-free medium for adenoviral infection. Adenoviruses Ad-
mCherry-mPrkag2 (WT)-FLAG and Ad-mCherry-mPrkag2(R299Q)-FLAG were
introduced into c-SANC by an acute adenoviral gene-transfer technique using a
MOI of 1,000 for 48 h. In addition to no adenoviral culture control, Ad-mCherry
was employed as an adenoviral vector control. All functional and immune-labeling
experiments were performed with cells cultured for 72 h.
Measurement of spontaneous beating rate and immuno-labeling of cultured
rabbit SA cells post-adenoviral transduction. In the three adenoviral-treated
groups, the density of mCherry was employed as a guide to successful infection
visualized via laser 543 nm (1 or 1.5% laser power). The bath superfusion solution
contained (in mmol/L): NaCl 140, KCl 5.4, MgCl2 1, HEPES 5, CaCl2 1.8, and
Glucose 5.5 (pH= 7.4). All functional measurements were performed at 34± 0.5 °C.
Spontaneous contraction was recorded via the line-scan of transmission image
using a confocal microscope (Zeiss LSM510, Carl Zeiss Inc., Germany) and the
spontaneous beating rate calculated from the average duration between peak
onsets74.
After each functional measurement, c-SANC were ﬁxed with 4%
Paraformaldehyde (10 min) for immuno-labeling. After permeabilization (1%
Triton X-100 in PBS, 15 min) and blocking (PBS with 2% IgG-free BSA, 5% donkey
serum, 0.02% NaN3, and 0.1% Triton X-100, 4 h), c-SANC were incubated with
primary anti-Flag M2 (1:100, Sigma) at 4 °C overnight and then stained with Cy5-
conjugated donkey anti-mouse secondary antibody (1:1000, Jackson
ImmunoResearch laboratories, USA) for 1 h74. In the negative control group, only
secondary antibody was applied. A 633 nm or 543 nm (at 10% power) laser was
employed to excite the ﬂuorophore Cy5 or mCherry via a confocal microscope
(Zeiss LSM510, Carl Zeiss Inc., Germany). For semi-quantiﬁcation, the average
density of Flag and mCherry were measured using ImageJ (1.48v, National Institute
of Health, USA), with the nuclear area excluded.
Echocardiography. Transthoracic echocardiography was undertaken as previously
described47. In brief, Sox2cre γ2 AMPK knockout and WT Cre+ mice aged
~2 months underwent general anesthesia with isoﬂurane (3–4% induction and
1–1.5% maintenance) in oxygen administered via nosecone. Images were acquired
on a heated platform using a Vevo 2100 Imaging System (VisualSonics, Toronto)
and analyzed off-line blind to genotype using Vevo software.
Surface ECG recordings. Anesthetized ECG recordings were obtained under light
isoﬂurane (1.25%) anesthesia. Four ﬁne needle electrodes were positioned sub-
cutaneously and a 5 min period of equilibration undertaken, prior to a 10 min ECG
recording with ﬁltering and ampliﬁcation of signals by Bio Ampliﬁer (ADInstru-
ments, Oxford, UK). ECG waveforms were then analyzed off-line using LabChart
software (ADInstruments) blind to genotype.
Voluntary wheel running and intact SA node/atrial preparation rate mea-
surement. Sox2cre γ2 AMPK knockout (Homo ﬂ Cre+) and WT Cre+ mice aged
3 months were singly housed in cages containing a freely rotating, angled running
track (Lillico, UK), with wheel rotations monitored by use of a reed switch con-
nected to a computerized exercise monitoring system (Micro 1401, CED, Cam-
bridge) as described75. Mice were allowed to acclimatize to single housing for
several days and then data was continuously recorded for 10 weeks. During this
period, cage disturbance was kept to a minimum, with ad libitum access to the
running wheel. Data acquisition and analysis blind to genotype were carried out
using Spike2 software (CED). For determination of intrinsic rate as part of these
experiments, atria were rapidly dissected and transferred to a 2 mL organ bath
containing Tyrode solution at 37± 0.5 °C, where they were allowed to equilibrate
as previously described37.
Statistical analysis. Data are presented as means± s.e.m. Numbers of mice were
determined by power calculations using in-house and available published data.
Unless otherwise stated, data were analyzed with Student’s t-test or one-way
analysis of variance (ANOVA) followed by Holm–Sidak’s multiple comparisons
test. Non-parametric data were analyzed by Kruskal–Wallis test followed by
Dunn’s multiple comparisons test. Statistical analysis was performed with
GraphPad Prism Software (v6.0, CA, USA) with P< 0.05 considered statistically
signiﬁcant.
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Data availability. Microarray and RNASeq datasets generated for this study have
been deposited in the Gene Expression Omnibus (Accession Number GSE73047)
and the Sequence Read Archive (Accession Number SRS1064711), respectively.
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